The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study.

作者: Erick de la Cruz-Hernández , Enrique Pérez-Cárdenas , Adriana Contreras-Paredes , David Cantú , Alejandro Mohar

DOI: 10.1186/1743-422X-4-18

关键词:

摘要: The methylation status at the human papilloma virus (HPV) genome found in pre-invasive and invasive cervical lesions suggests that neoplastic transformation can be suppressed by gene hypermethylation, whereas hypomethylation accompanies or causes cancer progression; hence, epigenetic therapy aimed reactivating cellular suppressor-gene expression has potential to act as a tumor promoter enhancing HPV oncoprotein HPV-related malignancies. objective of this study was determine influence hydralazine valproate on oncogene cell lines primary tumors patients undergoing treatment with valproate. Overall, either alone combined exerted growth inhibitory effect lines. A line-specific up-regulating observed E6/E7 expression, which general correlated DNA histone acetylation long control region (LCR). Nonetheless, unchanged decreased majority treated hydralazine, valproate, both. In some lines, these drugs led increased transcription p53, its stabilization due lysines 273 282, allowed higher bax-protein transactivating effect. results demonstrate safely administered malignancies such because they do not increase viral expression. Most importantly, antitumor may least partially depend an p53 valproate-induced hyperacetylation protein, protecting it from degradation E6.

参考文章(51)
Elizabeth E. Cameron, Kurtis E. Bachman, Sanna Myöhänen, James G. Herman, Stephen B. Baylin, Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nature Genetics. ,vol. 21, pp. 103- 107 ,(1999) , 10.1038/5047
Hui-Juan Yang, Vincent WS Liu, Yue Wang, Percy CK Tsang, Hextan YS Ngan, Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer. ,vol. 6, pp. 212- 212 ,(2006) , 10.1186/1471-2407-6-212
Pilar Zambrano, Blanca Segura-Pacheco, Enrique Perez-Cardenas, Lucely Cetina, Alma Revilla-Vazquez, Lucía Taja-Chayeb, Alma Chavez-Blanco, Enrique Angeles, Gustavo Cabrera, Karina Sandoval, Catalina Trejo-Becerril, Jose Chanona-Vilchis, Alfonso Duenas-González, A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer. ,vol. 5, pp. 44- 44 ,(2005) , 10.1186/1471-2407-5-44
Claudia Arce, Blanca Segura-Pacheco, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Myrna Candelaria, Alfonso Dueñnas-Gonzalez, Hydralazine target: From blood vessels to the epigenome Journal of Translational Medicine. ,vol. 4, pp. 10- 10 ,(2006) , 10.1186/1479-5876-4-10
Matthew D. Beal, Gregory A. Otterson, Romola R. Lakshmanan, Wei Guo Zhu, DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors Cancer Research. ,vol. 61, pp. 1327- 1333 ,(2001)
Theresa M. C. Tan, Robert C. Y. Ting, In Vitro and in Vivo Inhibition of Human Papillomavirus Type 16 E6 and E7 Genes Cancer Research. ,vol. 55, pp. 4599- 4605 ,(1995)
A Garcia-Carranca, F Thierry, M Yaniv, Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. Journal of Virology. ,vol. 62, pp. 4321- 4330 ,(1988) , 10.1128/JVI.62.11.4321-4330.1988
W A Burgers, L Blanchon, S Pradhan, Y de Launoit, T Kouzarides, F Fuks, Viral oncoproteins target the DNA methyltransferases. Oncogene. ,vol. 26, pp. 1650- 1655 ,(2007) , 10.1038/SJ.ONC.1209950
Bernd Gloss, Michele Yeo-Gloss, Michael Meisterernst, Lars Rogge, Ernst L. Winnacker, Hans-Ulrich Bernard, Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function Nucleic Acids Research. ,vol. 17, pp. 3519- 3533 ,(1989) , 10.1093/NAR/17.9.3519